COVID-19 Warp Speed Vaccine Initiative Faces Major Challenges, an Industrial Info Market Brief

Operation Warp Speed, a partnership between U.S. federal regulatory agencies and private drug producers, has set a deadline of January 2021 to develop, manufacture and distribute a viable COVID-19 vaccine. While there is great optimism in some quarters about achieving this feat, a healthy amount of skepticism remains.